Neogen Chemicals Ltd

Neogen Chemicals Ltd

₹ 1,552 1.08%
21 May 2:19 p.m.
About

Neogen Chemicals Ltd, incorporated in 1991, manufactures bromine and lithium-based organic and organo-metallic compounds, used in the pharmaceutical, agricultural chemicals, and engineering industries. [1]

Key Points

About
The company manufactures Bromine and Lithium-based chemical compounds.It also manufactures advanced intermediates in Pharma / Agro / Flavours and Fragrances. [1] Neogen is the largest importer of Lithium Carbonate & Lithium Hydroxide for last 3 decades – Strong Relationship with Global Leading Lithium Miners & Processors. [2]

  • Market Cap 4,094 Cr.
  • Current Price 1,552
  • High / Low 2,420 / 1,378
  • Stock P/E 94.9
  • Book Value 299
  • Dividend Yield 0.13 %
  • ROCE 8.82 %
  • ROE 5.57 %
  • Face Value 10.0

Pros

  • Company's median sales growth is 19.5% of last 10 years

Cons

  • Stock is trading at 5.23 times its book value
  • Company has a low return on equity of 6.93% over last 3 years.
  • Dividend payout has been low at 14.9% of profits over last 3 years
  • Promoter holding has decreased over last 3 years: -8.96%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
156.80 147.90 148.12 186.25 203.92 164.88 161.71 164.44 199.65 179.95 193.36 201.43 202.82
130.18 123.25 123.87 156.13 171.33 136.82 135.79 144.15 163.86 149.15 158.85 166.79 166.44
Operating Profit 26.62 24.65 24.25 30.12 32.59 28.06 25.92 20.29 35.79 30.80 34.51 34.64 36.38
OPM % 16.98% 16.67% 16.37% 16.17% 15.98% 17.02% 16.03% 12.34% 17.93% 17.12% 17.85% 17.20% 17.94%
0.93 0.94 0.48 1.40 1.75 1.81 1.94 1.67 2.23 1.59 0.84 1.14 -13.44
Interest 5.02 6.09 6.86 6.66 9.34 10.76 11.09 10.52 9.69 9.82 12.75 13.43 12.50
Depreciation 3.79 3.89 3.88 4.14 4.29 5.48 5.79 5.74 5.86 6.81 7.12 7.10 6.76
Profit before tax 18.74 15.61 13.99 20.72 20.71 13.63 10.98 5.70 22.47 15.76 15.48 15.25 3.68
Tax % 16.54% 28.89% 29.45% 29.10% 30.90% 28.47% 27.87% 81.40% 24.66% 27.22% 29.20% 34.36% 34.51%
15.64 11.10 9.87 14.69 14.31 9.75 7.92 1.06 16.93 11.47 10.96 10.01 2.41
EPS in Rs 6.27 4.45 3.96 5.89 5.74 3.91 3.18 0.40 6.42 4.35 4.15 3.79 0.91
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
74 84 100 110 161 239 306 336 487 686 691 778
62 71 86 90 132 196 248 272 401 575 581 641
Operating Profit 11 13 14 20 29 43 58 64 87 112 110 136
OPM % 16% 15% 14% 18% 18% 18% 19% 19% 18% 16% 16% 18%
0 1 0 0 1 1 0 1 1 5 8 -10
Interest 5 5 5 8 10 12 12 14 19 29 42 48
Depreciation 1 1 1 1 2 3 5 7 12 16 23 28
Profit before tax 6 8 8 12 17 29 41 44 57 71 53 50
Tax % 41% 37% 39% 33% 37% 28% 30% 29% 22% 30% 32% 31%
4 5 5 8 11 21 29 31 45 50 36 35
EPS in Rs 8.09 11.31 2.59 3.84 5.49 10.43 12.28 13.43 17.90 20.04 13.51 13.20
Dividend Payout % 25% 18% 17% 0% 18% 14% 16% 17% 15% 15% 22% 8%
Compounded Sales Growth
10 Years: 25%
5 Years: 20%
3 Years: 17%
TTM: 13%
Compounded Profit Growth
10 Years: 24%
5 Years: 9%
3 Years: -1%
TTM: 21%
Stock Price CAGR
10 Years: %
5 Years: 27%
3 Years: 3%
1 Year: 7%
Return on Equity
10 Years: 11%
5 Years: 9%
3 Years: 7%
Last Year: 6%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 4 4 20 20 20 20 23 23 25 25 26 26
Reserves 15 19 8 22 30 50 133 160 414 458 734 763
25 24 26 69 82 120 137 222 229 370 409 597
18 21 26 41 48 56 61 87 131 202 292 361
Total Liabilities 63 69 80 152 180 246 355 492 799 1,054 1,461 1,747
14 13 17 56 67 83 111 127 285 347 496 404
CWIP 0 0 1 1 1 0 3 115 11 36 109 156
Investments 0 0 0 0 0 1 1 1 82 77 0 0
49 55 62 94 112 163 241 250 422 594 856 1,187
Total Assets 63 69 80 152 180 246 355 492 799 1,054 1,461 1,747

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
9 9 0 12 -4 -35 84 1 -30 -29 196
-2 -4 -33 -13 -20 -29 -135 -146 -94 -216 -317
-6 -4 33 -0 24 63 51 188 100 237 113
Net Cash Flow 1 0 1 -1 0 -1 -0 44 -25 -8 -8

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 82 78 58 107 94 93 90 85 82 94 149 94
Inventory Days 173 178 190 228 192 188 257 211 258 275 365 267
Days Payable 117 120 130 177 141 111 71 122 131 147 138 227
Cash Conversion Cycle 138 136 117 158 145 169 276 174 209 223 376 134
Working Capital Days 140 140 126 174 142 162 217 164 190 205 272 312
ROCE % 27% 26% 23% 23% 26% 22% 17% 14% 13% 9% 9%

Shareholding Pattern

Numbers in percentages

12 Recently
Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
60.19% 60.19% 60.19% 60.18% 60.18% 60.18% 56.89% 56.89% 56.89% 51.22% 51.22% 51.22%
4.28% 3.74% 3.99% 4.13% 4.30% 4.25% 4.51% 4.56% 4.65% 8.17% 7.73% 7.79%
19.33% 19.12% 18.89% 20.01% 19.87% 20.25% 22.85% 22.14% 22.54% 22.48% 22.52% 22.75%
16.20% 16.96% 16.93% 15.68% 15.63% 15.32% 15.75% 16.42% 15.93% 18.12% 18.51% 18.22%
No. of Shareholders 38,64240,92649,48851,68647,58145,30047,01848,35646,69846,47047,65146,104

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Concalls